Terms: = Pancreatic cancer AND GOPC, FIG, 57120, ENSG00000047932, GOPC1, Q9HD26, CAL, dJ94G16_2 PIST AND Prognosis
6 results:
1. Initial Report: Personalized Circulating Tumor DNA and Survival in Patients with Resectable pancreatic cancer.
Eckhoff AM; Kanu E; Fletcher A; Bao M; Aushev VN; Spickard E; Nussbaum DP; Allen PJ
Ann Surg Oncol; 2024 Mar; 31(3):1444-1446. PubMed ID: 38170407
[TBL] [Abstract] [Full Text] [Related]
2. RCN1 deficiency inhibits oral squamous cell carcinoma progression and THP-1 macrophage M2 polarization.
Liu H; Guo H; Wu Y; Hu Q; Hu G; He H; Yin Y; Nan X; Lin G; Han J; Zhao R; Liu Y
Sci Rep; 2023 Dec; 13(1):21488. PubMed ID: 38057406
[TBL] [Abstract] [Full Text] [Related]
3. HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma.
Chen Y; Yang J; Jin H; Wen W; Xu Y; Zhang X; Wang Y
PeerJ; 2023; 11():e16237. PubMed ID: 37842043
[TBL] [Abstract] [Full Text] [Related]
4. The Intricate Metabolism of pancreatic cancers.
Camelo F; Le A
Adv Exp Med Biol; 2021; 1311():77-88. PubMed ID: 34014535
[TBL] [Abstract] [Full Text] [Related]
5. Ampullary cancer: an overview.
Ahn DH; Bekaii-Saab T
Am Soc Clin Oncol Educ Book; 2014; ():112-5. PubMed ID: 24857067
[TBL] [Abstract] [Full Text] [Related]
6. Detection of point mutations in KRAS oncogene by real-time PCR-based genotyping assay in GIT diseases.
Ugorcakova J; Hlavaty T; Novotna T; Bukovska G
Bratisl Lek Listy; 2012; 113(2):73-9. PubMed ID: 22394035
[TBL] [Abstract] [Full Text] [Related]
